Markets could be in for macro overload in the week ahead with central bankers, Friday's jobs report and OPEC dominating the headlines.» Read More
Citigroup expects relative outperformance in the card and payments sector although headwinds are forming, said the company’s analysts in a research report released Monday. Citi also raised its price target for American Express, MasterCard and Visa.
As the JPMorgan Health Care conference kicks off this week, one question remains for investors in the biotech space. What’s the next takeover target as large drug makers look to build out their pipeline?
Following a dismal 2011, emerging markets could see up to a 30 percent gain this year, assuming the sovereign debt crisis in the euro zone is kept at bay, according to Geoffrey Dennis, managing director at Citi.
It’s a tale of two stocks: Netflix flying 13.8 percent higher Monday while Zynga plummeted 9.2 percent. So what drove the big moves?
Discussing whether a shutdown of the Strait of Hormuz will send brent crude to $200, with Michael Wittener, SocGen, and the direction of oil, with the Fast Money traders.
Richard Pops, Alkermes chairman & CEO, discusses the challenges facing the health care industry; FDA approval of a once weekly diabetes drug, and other promising new drug candidates.
Charting a currency play on the Swiss franc and the New Zealand dollar, with Amelia Bourdeau, Westpac Institutional Bank.
Stocks squeezed out small gains Monday, adding to the previous week's robust rally, as investors turned their focus to fourth-quarter earnings season.
Shares of Sony have lost half its value in the past year. The company was hit on all fronts, drop in stock price, market share and natural disasters. Maria Bartiromo spoke exclusively with CEO Howard Stringer about all these issues and about speculation of management changes at Sony.
Alcoa's revenue numbers beat Street estimates. A breakdown of the company's cost-cutting and an outlook for the year, with Klaus Kleinfeld, Alcoa chairman/CEO.
CNBC's Julia Boorstin has the details behinds Netflix''s upside.
The European Central Bank is meeting on Thursday amid a wave of grim economic data. Here's one expert's take on what will happen.
Insight on whether dividend stocks can outperform in weakness and in strength, with Brian Belski, Oppenheimer & Co. and Victor Sperandeo, Alpha Financial Technologies.
CNBC's Herb Greenberg takes a look at whether Best Buy will go private, Dells plans to use strong cash flow to become a serial acquirer, and Lululemon's founder leaving the company.
"There's an old rule of thumb that the more negative you are going into earnings season...the more it allows for positive surprises and money to go in the market," says one market strategist.
Citi's chief US equity strategist is cautious on chemicals and health care, but says more merger and acquisition deals in energy and telecommunications will make them the sectors to watch.
Goldman Sachs analysts shook up its "conviction buy" list on Monday, adding Dow component Travelers Cos., apparel maker Ralph Lauren, and hedge fund Och-Ziff Capital Management as their best investment ideas.
CNBC's Rick Santelli has the update on bond yields and the dollar.
A look at what traders can expect given all the pre-announcements and the best plays right now, with Mike Holland, Holland & Company and Ned Riley, Riley Asset Management CEO.
Shares of many luxury-goods purveyors are up by double-digits over the past three months. One analyst from TheStreet.com details nine stocks that could benefit from wealthy people paying up for name-brand goods.